Andrea Fanjul

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Cannabinoid receptor type 1 (CB1) antibodies, encoding nucleic acid...
- Patent number 12,202,901
- Issue date Jan 21, 2025
- Takeda Pharmaceutical Company Limited
- Antara Banerjee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cannabinoid receptor type 1 (CB1) binding proteins and uses thereof
- Patent number 11,746,155
- Issue date Sep 5, 2023
- Takeda Pharmaceutical Company Limited
- Antara Banerjee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocycles for the treatment of diabetes and other di...
- Patent number 7,226,940
- Issue date Jun 5, 2007
- Incyte San Diego, Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic derivatives for the treatment of cancer and other prol...
- Patent number 7,153,875
- Issue date Dec 26, 2006
- Incyte San Diego
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-substituted heterocycles for the treatment of hypercholesteremia,...
- Patent number 7,071,218
- Issue date Jul 4, 2006
- Incyte San Diego Incorporated
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolidinedione derivatives for the treatment of diabetes and ot...
- Patent number 6,974,826
- Issue date Dec 13, 2005
- Incyte San Diego Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiazolidinedione derivatives for the treatment of diabetes and oth...
- Patent number 6,765,013
- Issue date Jul 20, 2004
- Incyte San Diego
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic derivatives for the treatment of diabetes and other di...
- Patent number 6,515,003
- Issue date Feb 4, 2003
- Maxia Pharmaceuticals, Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CANNABINOID RECEPTOR TYPE 1 (CB1) BINDING PROTEINS AND USES THEREOF
- Publication number 20220396620
- Publication date Dec 15, 2022
- Antara Banerjee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANNABINOID RECEPTOR TYPE 1 (CB1) BINDING PROTEINS AND USES THEREOF
- Publication number 20210198358
- Publication date Jul 1, 2021
- Takeda Pharmaceutical Company Limited
- Antara Banerjee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-substituted heterocycles for the treatment of hypercholesteremia,...
- Publication number 20060160796
- Publication date Jul 20, 2006
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted heterocycles for the treatment of diabetes and other di...
- Publication number 20060004059
- Publication date Jan 5, 2006
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RXR activating molecules
- Publication number 20050209286
- Publication date Sep 22, 2005
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazolidinedione derivatives for the treatment of diabetes and ot...
- Publication number 20050070581
- Publication date Mar 31, 2005
- Incyte San Diego, Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiazolidinedione derivatives for the treatment of diabetes and oth...
- Publication number 20030153606
- Publication date Aug 14, 2003
- Maxia Pharmaceuticals, Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-substituted heterocycles for the treatment of hypercholesteremia,...
- Publication number 20030144329
- Publication date Jul 31, 2003
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RXR activating molecules
- Publication number 20030105333
- Publication date Jun 5, 2003
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic derivatives for the treatment of cancer and other prol...
- Publication number 20020143182
- Publication date Oct 3, 2002
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY

Andrea Fanjul

Person

Patents Grantslast 30 patents

Cannabinoid receptor type 1 (CB1) antibodies, encoding nucleic acid...

Cannabinoid receptor type 1 (CB1) binding proteins and uses thereof

Substituted heterocycles for the treatment of diabetes and other di...

Heterocyclic derivatives for the treatment of cancer and other prol...

N-substituted heterocycles for the treatment of hypercholesteremia,...

Imidazolidinedione derivatives for the treatment of diabetes and ot...

Thiazolidinedione derivatives for the treatment of diabetes and oth...

Heterocyclic derivatives for the treatment of diabetes and other di...

Patents Applicationslast 30 patents

CANNABINOID RECEPTOR TYPE 1 (CB1) BINDING PROTEINS AND USES THEREOF

CANNABINOID RECEPTOR TYPE 1 (CB1) BINDING PROTEINS AND USES THEREOF

N-substituted heterocycles for the treatment of hypercholesteremia,...

Substituted heterocycles for the treatment of diabetes and other di...

RXR activating molecules

Imidazolidinedione derivatives for the treatment of diabetes and ot...

Thiazolidinedione derivatives for the treatment of diabetes and oth...

N-substituted heterocycles for the treatment of hypercholesteremia,...

RXR activating molecules

Heterocyclic derivatives for the treatment of cancer and other prol...